MacroGenics | MGNX - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
AbbVie USD 43.1B 1.46B 2026-09
Amgen USD 23.23B 2.27B 2026-09
AstraZeneca USD 31.27B 286M 2026-09
Biogen USD 3.9B 18.7M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Daiichi Sankyo JPY 882.78B 117.08B 2026-09
Eli Lilly USD 47B 745M 2026-09
Genmab DKK 1.14B 38M 2026-06
Geron USD 74.25M 3.92M 2026-09
Gilead Sciences USD 12B 982M 2026-09
J&J USD 55.46B 562M 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
Merck USD 28.8B 1.07B 2026-09
Pfizer USD 31.73B 920M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Xencor USD 76.27M 5.6M 2026-09